Olivet Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 07-07-2024
- Paid Up Capital ₹ 0.10 M
as on 07-07-2024
- Company Age 12 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.97 Cr
as on 07-07-2024
- Revenue -18.36%
(FY 2021)
- Profit 495.14%
(FY 2021)
- Ebitda 5.66%
(FY 2021)
- Net Worth 27.80%
(FY 2021)
- Total Assets 2.56%
(FY 2021)
About Olivet Pharma
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.97 Cr.
Syed Ali, Biplab Nandi, Sujoy Mitra, and One other member serve as directors at the Company.
- CIN/LLPIN
U51909WB2012PTC174202
- Company No.
174202
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Feb 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Olivet Pharma?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Syed Ali  | Director | 15-Feb-2012 | Current |
| Biplab Nandi | Director | 15-Feb-2012 | Current |
| Sujoy Mitra | Director | 15-Feb-2012 | Current |
| Sandipan Chakraborty | Director | 15-Feb-2012 | Current |
Financial Performance of Olivet Pharma.
Olivet Pharma Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 18.36% decrease. The company also saw a substantial improvement in profitability, with a 495.14% increase in profit. The company's net worth Soared by an impressive increase of 27.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Olivet Pharma?
In 2021, Olivet Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Phoenix Hospital & Diagnostic Centre Private LimitedActive 24 years 9 monthsSyed Ali, Biplab Nandi and 2 more are mutual person
La Revas Pharma Private LimitedActive 6 years 3 monthsSyed Ali, Biplab Nandi and 2 more are mutual person
Elation Hair & Skin Clinic Private LimitedActive 9 years 6 monthsSyed Ali, Biplab Nandi and 2 more are mutual person
Phoenix Medical Centre Private LimitedActive 2 years 11 monthsSyed Ali, Biplab Nandi and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 17 May 2023 | ₹1.10 M | Open |
Hdfc Bank Limited Creation Date: 07 Sep 2022 | ₹0.70 M | Open |
Axis Bank Limited Creation Date: 05 Aug 2022 | ₹1.02 Cr | Open |
How Many Employees Work at Olivet Pharma?
Olivet Pharma has a workforce of 7 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Olivet Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Olivet Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
